This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mehta SR et al.; Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358: 527–533
Hongo RH et al. (2002) The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 40: 231–237
Stroobant N et al. (2005) Relation between neurocognitive impairment, embolic load, and cerebrovascular reactivity following on-and off-pump coronary artery bypass grafting. Chest 127: 1967–1976
Jones RH (2006) The year in cardiovascular surgery. J Am Coll Cardiol 47: 2094–2107
Akowuah E et al. (2005) Comparison of two strategies for the management of antiplatelet therapy during urgent surgery. Ann Thorac Surg 1: 149–152
Mangano DT et al.; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354: 353–365
Acknowledgements
The synopsis was written by Hannah Camm, Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The Duke University catheterization laboratory conference that PB Berger directs has received unrestricted educational grants from Sanofi Aventis, Lilly, Sankyo, Datascope, Johnson and Johnson, The Medicine Company, Boston Scientific and Medtronic. He has received research support from Boehringer Ingelheim, Conor, Cardiokinetix and Guilford. He has spoken at scientific symposia supported by Bristol-Myers Squibb, Sanofi Aventis, Arginox and Schering Plough. He has served as a consultant to Johnson and Johnson, Boston Scientific, Genetech and Guilford. K Skelding declared she has no competing interests.
Rights and permissions
About this article
Cite this article
Skelding, K., Berger, P. Does clopidogrel pretreatment counteract the benefits of off-pump CABG surgery?. Nat Rev Cardiol 3, 530–531 (2006). https://doi.org/10.1038/ncpcardio0652
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0652
This article is cited by
-
Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass
Journal of Thrombosis and Thrombolysis (2012)